Abate Kristin
SEC CIK 2045943 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | CAO | 23.8K | — | $14.8K | 15 | 2025-02-28 | 2026-09-01 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 16:57 | 2026-09-01 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $2.02 | -19 | 23.8K | -0.1% | -$38.38 | |
| 2026-05-15 16:04 | 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | A - Grant | $0.00 | +121 | 23.9K | +0.5% | $0 | |
| 2026-05-15 16:04 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $9.50 | -53 | 23.8K | -0.2% | -$503.50 | |
| 2026-03-03 | 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $9.41 | -559 | 22.1K | -2% | -$5,260 | |
| 2026-01-29 | 2026-01-28 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $7.03 | -50 | 22.6K | -0.2% | -$351.50 | |
| 2026-01-29 | 2026-01-27 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | A - Grant | $0.00 | +92 | 22.7K | +0.4% | $0 | |
| 2026-01-22 | 2026-01-21 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $5.96 | -265 | 22.6K | -1% | -$1,579 | |
| 2025-10-16 | 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | A - Grant | $0.00 | +12.8K | 22.8K | +127% | $0 | |
| 2025-10-03 | 2025-10-01 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $6.30 | -362 | 10.0K | -3% | -$2,281 | |
| 2025-09-16 | 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | A - Grant | $0.00 | +46 | 10.4K | +0.4% | $0 | |
| 2025-09-16 | 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $6.43 | -23 | 10.4K | -0.2% | -$147.89 | |
| 2025-09-04 | 2025-09-03 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $6.78 | -12 | 9,463 | -0.1% | -$81.36 | |
| 2025-07-23 | 2025-07-22 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $4.00 | -238 | 9,475 | -2% | -$952 | |
| 2025-03-06 | 2025-03-04 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | S - Sale | $6.29 | -571 | 9,713 | -6% | -$3,592 | |
| D | 2025-03-04 | 2025-02-28 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | CAO | A - Grant | $0.00 | +933 | 10.3K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations